Erchonia has received 510(k) clearance from the US Food and Drug Administration for its low level laser technology to treat whole-body postoperative pain.
Melbourne, FL (PRWEB) November 01, 2021 Erchonia, the World Leader in Low Level laser Technology announces that on October 22, 2021, they have received